Trademark applications and grants for Globeimmune Inc. Globeimmune Inc has 8 trademark applications. The latest application filed is for "GBIM"
Patent Application | Date |
---|---|
ANTI COVID-19 THERAPIES USING NUCLEOCAPSID AND SPIKE PROTEINS 20220023415 - 17/448033 King; Thomas H. | 2022-01-27 |
METHODS AND COMPOSITIONS FOR MODULATING MYELOID-DERIVED SUPPRESSOR CELLS 20210290708 - 17/264624 SOON-SHIONG; Patrick ;   et al. | 2021-09-23 |
Anti COVID-19 Therapies targeting nucleocapsid and spike proteins 20210283245 - 16/883263 Niazi; Kayvan ;   et al. | 2021-09-16 |
LYSATES OF RECOMBINANT YEAST FOR INDUCING CELLULAR IMMUNE RESPONSES 20210154250 - 17/047134 KING; Thomas H. ;   et al. | 2021-05-27 |
Combination Immunotherapy Compositions Against Cancer and Methods 20210113677 - 17/130551 Hodge; James ;   et al. | 2021-04-22 |
NCAGE Code | 60QV0 | GLOBEIMMUNE, INC. |
CAGE Code | 60QV0 | GLOBEIMMUNE, INC. |
S.A.M. Registration | 60QV0 [130074495] | GLOBEIMMUNE, INC. |
SEC | 0001245104 | GLOBEIMMUNE INC of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.